A Trial to Investigate Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BioChaperone® Pramlintide Insulin in Patients With Type 1 Diabetes Mellitus
Phase of Trial: Phase I
Latest Information Update: 18 Jul 2018
At a glance
- Drugs Insulin lispro/pramlintide (Primary)
- Indications Type 1 diabetes mellitus
- Focus First in man; Pharmacokinetics
- Sponsors Adocia
- 18 Jul 2018 According to an Adocia media release, top-line results from the trial are expected in Q3 2018.
- 19 Apr 2018 Status changed from planning to not yet recruiting.
- 16 Apr 2018 According to an Adocia media release, Status changed from not yet recruiting to recruiting.